In a report released on March 21, David Evans from Kepler Capital maintained a Buy rating on Novartis AG (NOVN – Research Report), with a ...

Neoplastic Agents Market Report 2025" has been added to ResearchAndMarkets.com's offering.This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, ...

Connor Clark & Lunn Investment Management Ltd. lowered its position in Novartis AG (NYSE:NVS – Free Report) by 95.6% in the 4th quarter, according to the company in its most recent Form 13F filing ...

Merck & Co. will pay as much as $2 billion for the rights to Jiangsu Hengrui Pharmaceuticals Co.’s experimental heart drug, ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The global CAR T-cell therapy market is projected to grow from USD 2.7 billion in 2025 to over USD 27.5 billion by 2033, reflecting a robust CAGR of 26.2%.

By Medha Singh (Reuters) -European shares fell on Wednesday, led by declines in healthcare stocks, while caution prevailed ahead of a fresh round of U.S. tariffs set to take effect next week. The ...

Syngenta's full-year report shows agriculture caught up in worldwide economic waves but sees improvement in 2025.

In 2005, Sandoz became the world leader in generic pharmaceuticals after acquiring Germany's Hexal AG and US-based Eon Labs. The same year, Novartis acquired the North American over-the-counter ...